Literature DB >> 1288865

Intimal proliferation in an organ culture of human internal mammary artery.

C M Holt1, S E Francis, S Rogers, P A Gadsdon, T Taylor, C Clelland, A Soyombo, A C Newby, G D Angelini.   

Abstract

OBJECTIVE: Intimal smooth muscle cell proliferation is an early feature of atherosclerosis. Its progression is difficult to monitor in humans and previous studies have mostly relied on necropsy material. The aim of this study was therefore to establish whether intimal proliferation occurred in an organ culture of human internal mammary artery.
METHODS: Segments of freshly isolated internal mammary artery were maintained din standard tissue culture medium containing 30% calf serum for 14 d. Tissue viability (measured by ATP concentration) was maintained during processing and throughout the culture period [211(SEM 28) nmol ATP.g-1 wet weight on d 1 v 208(27) on d 14].
RESULTS: Histological transverse sections of cultured internal mammary artery showed the development of a neointima containing smooth muscle cells identified by immunocytochemistry for alpha actin. Pulse labelling of cultures with [3H]-thymidine showed proliferating cells predominantly in a neointimal layer with few dividing cells in the media. Cultured de-endothelialized vessels showed less neointimal thickening than cultured freshly isolated vessels [16(3) v 36(5) microns, p < 0.0025] as well as a reduced number of dividing cells per mm of neointimal length [3.1(0.6) v 5.5(1.1), p < 0.05].
CONCLUSIONS: Intimal proliferation occurred in organ culture of internal mammary artery. There is evidence for a factor derived from the endothelium, which may be important in the development of intimal proliferation.

Entities:  

Mesh:

Year:  1992        PMID: 1288865     DOI: 10.1093/cvr/26.12.1189

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue.

Authors:  R Ziesche; V Petkov; J Williams; S M Zakeri; W Mosgöller; M Knöfler; L H Block
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Nature and origin of the neointima in whole vessel wall organ culture of the human saphenous vein.

Authors:  J Slomp; A C Gittenberger-deGroot; J C van Munsteren; H A Huysmans; J H van Bockel; V W van Hinsbergh; R E Poelmann
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

3.  Human internal mammary artery (IMA) transplantation and stenting: a human model to study the development of in-stent restenosis.

Authors:  Xiaoqin Hua; Tobias Deuse; Evangelos D Michelakis; Alois Haromy; Phil S Tsao; Lars Maegdefessel; Reinhold G Erben; Claudia Bergow; Boris B Behnisch; Hermann Reichenspurner; Robert C Robbins; Sonja Schrepfer
Journal:  J Vis Exp       Date:  2012-05-09       Impact factor: 1.355

4.  Enhanced cytomegalovirus infection in atherosclerotic human blood vessels.

Authors:  Pamela L Nerheim; Jeffery L Meier; Mohammad A Vasef; Wei-Gen Li; Ling Hu; James B Rice; Daniel Gavrila; Wayne E Richenbacher; Neal L Weintraub
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

5.  SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery.

Authors:  L Lipskaia; L Hadri; P Le Prince; B Esposito; F Atassi; L Liang; M Glorian; I Limon; A-M Lompre; S Lehoux; R J Hajjar
Journal:  Gene Ther       Date:  2012-07-05       Impact factor: 5.250

6.  PDGF regulates guanylate cyclase expression and cGMP signaling in vascular smooth muscle.

Authors:  Staffan Hildebrand; Mohamed Ibrahim; Andreas Schlitzer; Lars Maegdefessel; Wilhelm Röll; Alexander Pfeifer
Journal:  Commun Biol       Date:  2022-03-03

7.  Halofuginone inhibits neointimal formation of cultured rat aorta in a concentration-dependent fashion in vitro.

Authors:  K Liu; S Sekine; Y Goto; K Iijima; I Yamagishi; K Kondon; M Matsukawa; T Abe
Journal:  Heart Vessels       Date:  1998       Impact factor: 1.814

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.